Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Veracyte is a leading US-based genomic diagnostics company. It develops and markets advanced tests for precise cancer diagnosis and treatment decisions, particularly for lung and thyroid cancers. The company enhances patient care through innovative biomarker-based precision medicine solutions.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Veracyte is scheduled to report its next quarterly earnings on 11/10/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Veracyte last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at 0.54 USD.
Across its last 3 earnings reports, Veracyte stock moved by ±20.3% on average the following day. The largest reaction was +27.5% on 11/04/2025; 3 of 3 reactions were positive.
Veracyte has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.